Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong
/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg...
Stay updated with breaking news from Trial Version. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg...
/PRNewswire/ -- On March 19, the Media Briefing on Prevention and Control of COVID-19 with Lianhua Qingwen Capsules, a patented Chinese medicine developed and...
/PRNewswire/ -- On March 19, the Media Briefing on Prevention and Control of COVID-19 with Lianhua Qingwen Capsules, a patented Chinese medicine developed and...
SHIJIAZHUANG, China, March 21, 2022 /PRNewswire/ -- On March 19, the Media Briefing on Prevention and Control of COVID-19 with Lianhua Qingwen Cap...
The recently released Realme X7 Pro entered the Android 12-based Realme UI 3.0 early access program. There are limited seats.